Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2015 2
2016 3
2017 7
2018 3
2019 2
2020 2
2021 3
2022 3
2023 7
2024 11
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Immune checkpoint inhibitor-related dermatologic adverse events.
Geisler AN, Phillips GS, Barrios DM, Wu J, Leung DYM, Moy AP, Kern JA, Lacouture ME. Geisler AN, et al. Among authors: moy ap. J Am Acad Dermatol. 2020 Nov;83(5):1255-1268. doi: 10.1016/j.jaad.2020.03.132. Epub 2020 May 23. J Am Acad Dermatol. 2020. PMID: 32454097 Free PMC article. Review.
Management of immune-related cutaneous adverse events with dupilumab.
Kuo AM, Gu S, Stoll J, Moy AP, Dusza SW, Gordon A, Haliasos EC, Janjigian Y, Kraehenbuehl L, Quigley EA, Chapman P, Lacouture ME, Markova A. Kuo AM, et al. Among authors: moy ap. J Immunother Cancer. 2023 Jun;11(6):e007324. doi: 10.1136/jitc-2023-007324. J Immunother Cancer. 2023. PMID: 37270183 Free PMC article.
Aggressive Cutaneous Lymphomas and Their Mimics.
Moy AP, Pulitzer MP. Moy AP, et al. Surg Pathol Clin. 2023 Jun;16(2):361-383. doi: 10.1016/j.path.2023.01.009. Epub 2023 Mar 10. Surg Pathol Clin. 2023. PMID: 37149363 Review.
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.
Lacouture ME, Goleva E, Shah N, Rotemberg V, Kraehenbuehl L, Ketosugbo KF, Merghoub T, Maier T, Bang A, Gu S, Salvador T, Moy AP, Lyubchenko T, Xiao O, Hall CF, Berdyshev E, Crooks J, Weight R, Kern JA, Leung DYM. Lacouture ME, et al. Among authors: moy ap. Clin Cancer Res. 2024 Jul 1;30(13):2822-2834. doi: 10.1158/1078-0432.CCR-23-3431. Clin Cancer Res. 2024. PMID: 38652814 Free PMC article.
Phenotype/Immunologic Profiling in ircAEs-Response.
Goleva E, Lacouture ME, Moy AP, Kern JA, Leung DYM. Goleva E, et al. Among authors: moy ap. Clin Cancer Res. 2024 Dec 16;30(24):5694. doi: 10.1158/1078-0432.CCR-24-2949. Clin Cancer Res. 2024. PMID: 39676538 No abstract available.
Spatial Immunophenotyping from Whole-Slide Multiplexed Tissue Imaging Using Convolutional Neural Networks.
Yosofvand M, Edmiston SN, Smithy JW, Peng X, Kostrzewa CE, Lin B, Ehrich F, Reiner A, Miedema J, Moy AP, Orlow I, Postow MA, Panageas K, Seshan VE, Callahan MK, Thomas NE, Shen R. Yosofvand M, et al. Among authors: moy ap. bioRxiv [Preprint]. 2024 Aug 19:2024.08.16.608247. doi: 10.1101/2024.08.16.608247. bioRxiv. 2024. PMID: 39229153 Free PMC article. Preprint.
Quantitatively defined stromal B cell aggregates are associated with response to checkpoint inhibitors in unresectable melanoma.
Smithy JW, Peng X, Ehrich FD, Moy AP, Yosofvand M, Maher C, Aleynick N, Vanguri R, Zhuang M, Lee J, Bleile M, Li Y, Postow MA, Panageas KS, Hollmann TJ, Callahan MK, Shen R. Smithy JW, et al. Among authors: moy ap. Cell Rep. 2025 Apr 22;44(4):115554. doi: 10.1016/j.celrep.2025.115554. Epub 2025 Apr 11. Cell Rep. 2025. PMID: 40220297 Free PMC article.
40 results